Better Therapeutics, Inc.
BTTX
Rank in Stocks
#34700
Better Therapeutics, Inc., a prescription digital therapeutics company,... Better Therapeutics, Inc., a prescription digital therapeutics company, develops a form of cognitive behavioral therapy to address the causes of cardiometabolic diseases. The company’s lead product candidate is BT-001, an investigational PDT platform to treat type 2 diabetes. It also develops software-based prescription digital therapeutics platform candidates for treating diabetes, heart disease, and other cardiometabolic conditions. In addition, the company’s clinical development candidates are intended to treat cardiometabolic diseases, including type 2 diabetes, hypertension, hyperlipidemia, Metabolic Dysfunction-Associated Steatotic Liver Disease, Metabolic Dysfunction-Associated Steatohepatitis ,and chronic kidney disease. Its product pipeline also includes BT-002, which intends glycemic control for hypertension; BT-003 to reduce LDL cholesterol in patients with hyperlipidemia; and BT-004, which intends to explore the impact of treatment on liver health in patients with non-alcoholic steatohepatitis/non-alcoholic fatty liver disease. The company was founded in 2015 and is headquartered in San Francisco, California.
Share Price
$0.0001
Last synced: 2026-11-10
Market Cap
$3.85K
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
Stock data: Financial Modeling Prep·Updated ·Not investment advice·How we calculate this
Trade Better Therapeutics, Inc. (BTTX)
Category
Healthcare
EPS for Better Therapeutics, Inc. (BTTX)
EPS as of September 2023 TTM: $-1.15
According to Better Therapeutics, Inc.'s latest financial reports, its current EPS (TTM) is $-1.15. At the end of 2022 the company had an EPS of $-1.69, an increase over its 2021 EPS of $-1.71.
EPS history for Better Therapeutics, Inc. from 2019 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-1.15 | -31.95% |
| 2022 | $-1.69 | -1.17% |
| 2021 | $-1.71 | 64.42% |
| 2020 | $-1.04 | 316.00% |
| 2019 | $-0.25 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $8.45 | -834.78% |
IE
|
|
| $0.21 | -118.13% |
CN
|
|
| $19.69 | -1,812.07% |
CH
|
|
| $4.34 | -477.22% |
CH
|
|
| $0.13 | -110.96% |
CN
|
Questions about Better Therapeutics, Inc.'s earnings per share (EPS)
What is Better Therapeutics, Inc.'s earnings per share (EPS)?
Better Therapeutics, Inc.'s earnings per share (EPS) over the last twelve months is $-1.15, as of Sep 2023.
What was Better Therapeutics, Inc.'s earnings per share (EPS) in 2022?
In 2022, Better Therapeutics, Inc.'s earnings per share (EPS) was $-1.69, compared with $-1.71 in 2021.
How has Better Therapeutics, Inc.'s earnings per share (EPS) changed since 2019?
From 2019 to 2022, Better Therapeutics, Inc.'s earnings per share (EPS) was highest in 2019 ($-0.25) and lowest in 2021 ($-1.71).
How does Better Therapeutics, Inc.'s earnings per share (EPS) compare with similar companies?
Better Therapeutics, Inc.'s earnings per share (EPS) ($-1.15) is lower than that of all 5 similar companies listed above. The highest among them is Ypsomed Holding AG, with $19.69.